TrialBlood advances2023

Sequencing T-cell redirection therapies leads to deep and durable responses in patients with relapsed/refractory myeloma.

Tarek H Mouhieddine et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.